Novo Nordisk announced two seperate investments in the past two weeks as it races to meet global de…

Patients and doctors share their perspectives on the biggest ever revolution in obesity medicine.

Semaglutide, a medication to treat diabetes, is gaining popularity for weight loss on apps like Tik…

Novo Nordisk's market valuation has soared to $413 billion, exceeding Denmark's estimated 2022 GDP …

Kids as young as 12 can now take Wegovy. Parents are struggling with how to put their kids on weigh…

Under a new system for recording drug and alcohol violations, 72,000 drivers are currently prohibit…

"We see highest risk to alcohol, snacking relative to meals, and non-alcoholic beverages," Bank of …

Indian pharma companies are expected to benefit from improving demand in the US market, said India …

The FDA in June approved semaglutide to treat obesity. Its maker has suggested it's so popular that…

The ongoing formula shortages linked to product recalls have impacted the availability of formula d…

The air traffic controller workforce has been severely stretched, with staffing shortages leading t…

Tirzepatide, marketed as Mounjaro for diabetes, could soon become the latest weight loss drug to be…

In a new study, patients on tirzepatide (Mounjaro) lost nearly 16% of their body weight in 16 month…

As of December, more than 60,000 truckers have been temporarily taken off the road for testing posi…

The author says the Adderall shortage has pushed doctors to prescribe other ADHD medications, which…

The government has started importing the vital drug from other countries to ease its shortage i…

After founding SiriusXM in the 1990s, Martine Rothblatt is now running a biotech pushing the bounda…

Ozempic and Wegovy are a hit with Hollywood celebrities. Now, injectable weight-loss drugs are conq…

Current law only requires inspections of baby formula facilities every three to five years, but the…

The shortage resulted after an Abbott plant closed due to strains of bacteria potentially deadly to…